









Markets
/
Stocks
/
nasdaq-drma
/

Dermata Therapeutics Inc

DRMA

7.060USD

+0.610+9.46%

Close 08/04, 16:00（ET）Quotes delayed by 15 min

42.59MMarket Cap

LossP/E TTM



Dermata Therapeutics Inc

7.060

+0.610+9.46%

Overview Company Financials

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

28.49%-1.93M

-153.95%-2.91M

-92.98%-3.42M

-15.52%-2.13M

-63.94%-2.70M

37.15%-1.15M

30.83%-1.77M

-0.05%-1.84M

36.74%-1.65M

-1.20%-1.83M

-15.89%-2.56M

-103.66%-1.84M

-235.97%-2.61M

-236.57%-1.80M

-61.36%-2.21M

-21.42%-903.21K

43.71%-776.22K

---535.97K

---1.37M

---743.89K

---1.38M

Net income from continuing operations

26.50%-2.30M

-47.66%-3.15M

-84.57%-3.17M

-66.28%-2.83M

-39.91%-3.13M

-27.81%-2.13M

29.09%-1.72M

37.69%-1.70M

19.60%-2.24M

34.60%-1.67M

-41.55%-2.42M

-105.03%-2.73M

-20.88%-2.79M

-544.15%-2.55M

-186.73%-1.71M

-62.09%-1.33M

-62.18%-2.30M

---396.31K

---597.39K

---821.65K

---1.42M

Operating gains losses

----

--0.00

-100.00%0.00

--0.00

--322.00

Other non-cash items

----

-100.00%0.00

-99.03%156.00

-99.49%78.00

-75.62%13.89K

--8.81K

--16.13K

--15.18K

--56.98K

Change in working capital

311.10%332.33K

-75.82%207.51K

-45.30%-266.76K

353.00%683.54K

-134.28%-157.43K

327.75%858.20K

50.60%-183.59K

-142.92%-270.18K

1428.23%459.25K

-244.80%-376.82K

41.92%-371.67K

100.15%629.49K

-109.75%-34.58K

1848.86%260.23K

18.83%-639.94K

402.55%314.51K

2434.02%354.75K

---14.88K

---788.35K

--62.58K

---15.20K

-Change in prepaid expenses

-8.31%86.58K

13.13%171.28K

11.17%-370.90K

7.63%273.38K

-46.00%94.42K

-26.10%151.40K

18.05%-417.55K

-44.12%254.00K

726.18%174.85K

-20.38%204.87K

-36.68%-509.52K

216.87%454.51K

88.64%-27.92K

6454.05%257.31K

-473.80%-372.78K

-1106.16%-388.89K

-1269.13%-245.72K

--3.93K

---64.97K

--38.65K

--21.02K

-Change in other current liabilities

----

--0.00

---500.00K

----

Cash from non-recurring investing activities

Cash from operating activities

28.49%-1.93M

-153.95%-2.91M

-92.98%-3.42M

-15.52%-2.13M

-63.94%-2.70M

37.15%-1.15M

30.83%-1.77M

-0.05%-1.84M

36.74%-1.65M

-1.20%-1.83M

-15.89%-2.56M

-103.66%-1.84M

-235.97%-2.61M

-236.57%-1.80M

-61.36%-2.21M

-21.42%-903.21K

43.71%-776.22K

---535.97K

---1.37M

---743.89K

---1.38M

Investing cash flow

Cash from non-current investing activities

Financing cash flow

Cash flow from continuous financing activities

--8.49M

-103.51%-68.57K

13131.36%4.62M

54.71%2.34M

-100.00%0.00

--1.95M

-17809.50%-35.42K

-64.64%1.51M

--4.18M

100.00%0.00

-100.00%200.00

--4.28M

-100.00%0.00

-100.20%-626.00

937.99%14.39M

-100.00%0.00

--1.58M

--313.33K

--1.39M

--867.85K

--0.00

Net cash flow from debt Issuance/repayment

----

--0.00

-100.00%0.00

--1.01M

--313.33K

--1.37M

--617.85K

--0.00

Net cash flow from common stock issuance/repurchase

--8.54M

-103.56%-69.51K

12933.26%4.55M

59.39%2.41M

-100.00%0.00

--1.95M

---35.42K

-64.64%1.51M

--4.17M

--0.00

-100.00%0.00

--4.28M

----

--15.39M

----

Net cash flow from preferred stock issuance/repurchase

----

100.00%0.00

--0.00

-100.00%0.00

--0.00

-5433.33%-1.00M

-100.00%0.00

--570.00K

--0.00

--18.75K

--250.00K

--0.00

Proceeds from issuance of warrants

--977.00

--941.00

--168.00

-100.00%0.00

--0.00

-100.00%0.00

-60.92%34.00

--153.00

--0.00

--200.00

--87.00

----

Net cash flow from other financing activities

---50.49K

--0.00

--70.00K

---70.83K

100.00%0.00

--0.00

---40.00

----

---626.00

----

Net cash from non-recurrent financing activities

Net cash from financing activities

--8.49M

-103.51%-68.57K

13131.36%4.62M

54.71%2.34M

-100.00%0.00

--1.95M

-17809.50%-35.42K

-64.64%1.51M

--4.18M

100.00%0.00

-100.00%200.00

--4.28M

-100.00%0.00

-100.20%-626.00

937.99%14.39M

-100.00%0.00

--1.58M

--313.33K

--1.39M

--867.85K

--0.00

Net cash flow

Beginning cash balance

-57.50%3.16M

-7.35%6.14M

-41.37%4.95M

-46.00%4.73M

19.18%7.44M

-17.79%6.63M

-20.60%8.44M

7.03%8.77M

-42.20%6.24M

-35.99%8.07M

2387.79%10.63M

515.67%8.19M

1935.97%10.80M

1573.65%12.60M

-42.01%427.20K

117.13%1.33M

-73.37%530.40K

--753.05K

--736.70K

--612.74K

--1.99M

Current period cash flow changes

342.48%6.56M

-469.70%-2.98M

166.22%1.20M

165.02%213.42K

-207.09%-2.70M

144.19%806.65K

29.44%-1.81M

-113.47%-328.23K

196.84%2.53M

-1.16%-1.83M

-121.03%-2.56M

369.81%2.44M

-425.97%-2.61M

-710.50%-1.80M

74376.35%12.18M

-828.62%-903.21K

158.01%800.01K

---222.65K

--16.35K

--123.96K

---1.38M

Ending cash balance

105.32%9.72M

-57.50%3.16M

-7.35%6.14M

-41.37%4.95M

-46.00%4.73M

19.18%7.44M

-17.79%6.63M

-20.60%8.44M

7.03%8.77M

-42.20%6.24M

-35.99%8.07M

2387.79%10.63M

515.67%8.19M

1935.97%10.80M

1573.65%12.60M

-42.01%427.20K

117.13%1.33M

--530.40K

--753.05K

--736.70K

--612.74K

Currency unit

USD

Audit opinions

KeyAI

